PlatinumRx
PrivateLast Round
Series A
Sep 3, 2025
Total Funding Raised
$6.8M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
PlatinumRx operates in Healthcare & Life Sciences and is based in Bangalore. Its latest recorded funding round was a Series A round in September 2025.
PlatinumRx is a healthcare company that operates an online pharmacy and tele-consultation platform providing affordable generic medicine substitutes to patients in India.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, E-commerce, Telemedicine, Patient Engagement
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PlatinumRx Comparables
Compare PlatinumRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tata Steel Limited | 84% | |
| Truemeds | 77% | |
| Pharmapick Services Private Limited | 77% |
For institutional investors. Book with your work email.
PlatinumRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 3, 2025 | ||||
| Seed | Apr 8, 2024 |
For institutional investors. Book with your work email.
PlatinumRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| India Quotient | Series A, Seed |
| Stellaris Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2026
Grew 40% QoQ, adding 36 employees.
- Sep 13, 2026
Monthly visitors grew 40% MoM, reaching 2.9 million.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingNov 12, 2026
PlatinumRx Group is in talks to raise $32M in a funding round led by Sofina Ventures at a $150M–$200M valuation in India.
For institutional investors. Book with your work email.
PlatinumRx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PlatinumRx's valuation, stock price, and market status.
Is PlatinumRx a public or private company?
PlatinumRx is a private company.
What is the current stock price of PlatinumRx?
PlatinumRx is a private company, so its shares have no public market price. Caplight tracks PlatinumRx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PlatinumRx worth (valuation)?
Valuation information for PlatinumRx is not publicly available.
Can I buy PlatinumRx stock?
PlatinumRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PlatinumRx's last funding round?
PlatinumRx's most recent funding round was Series A on September 3, 2025.
Who are the main investors in PlatinumRx?
Key investors in PlatinumRx include India Quotient, Stellaris Venture Partners.
Will PlatinumRx IPO soon?
No public IPO plans have been announced for PlatinumRx.
How can I track PlatinumRx secondary market activity?
Caplight tracks bids, offers, and trades in PlatinumRx's shares on secondary markets.